Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales

Andrew J. McArdle, Victoria Austin

Open source

DOI
10.1128/jcm.00293-26
Published
2026-06-10
Container
Journal of Clinical Microbiology
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/jcm.00293-26,
  title = {Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales},
  author = {Andrew J. McArdle and Victoria Austin},
  year = {2026},
  journal = {Journal of Clinical Microbiology},
  doi = {10.1128/jcm.00293-26},
  url = {https://doi.org/10.1128/jcm.00293-26}
}

RIS

TY  - JOUR
TI  - Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales
AU  - Andrew J. McArdle
AU  - Victoria Austin
PY  - 2026
JO  - Journal of Clinical Microbiology
DO  - 10.1128/jcm.00293-26
UR  - https://doi.org/10.1128/jcm.00293-26
ER  - 

APA

McArdle, A. J., & Austin, V. (2026). Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00293-26

Source records